India  

"Dr Reddy"

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 
Monoclonal antibodies control Covid symptoms in 24 hours, says AIG chairman Dr Reddy | Oneindia News [Video]

Monoclonal antibodies control Covid symptoms in 24 hours, says AIG chairman Dr Reddy | Oneindia News

Around 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad-based Asian Institute of Gastroenterology. Chairperson of the hospital, Dr Nageshwar Reddy said..

Credit: Oneindia     Duration: 01:40Published
Covid-19: 75 patients died at Goa's biggest hospital in past four days| Oneindia News [Video]

Covid-19: 75 patients died at Goa's biggest hospital in past four days| Oneindia News

Seventy-five patients have died at the Goa Medical College and Hospital the state's biggest Covid facility in the past four days. With disturbing reports of mishandling of Covid-19 bodies emerging..

Credit: Oneindia     Duration: 03:01Published

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials [Video]

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials

Institute of Nuclear Medicine and Allied Sciences-DRDO scientist Dr Sudhir Chandna on drug 2-deoxy-D-glucose (2-DG) while speaking to ANI informed about the observations of the medicine's clinical..

Credit: ANI     Duration: 01:59Published
Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen [Video]

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen

From DCGI approving new anti-Covid drug, to health ministry issues new rules for hospital admissions, here are the top updates on the coronavirus. DCGI approved a new anti-Covid oral drug, which has..

Credit: HT Digital Content     Duration: 03:24Published
Sensex up 424 points as RBI unveils COVID relief measures [Video]

Sensex up 424 points as RBI unveils COVID relief measures

Key equity indices traded in the green on Wednesday as RBI Governor Shaktikanta Das launched the second round of loan restructuring and other relief measures to counter the impact of Covid-19's second..

Credit: ANI     Duration: 01:12Published
Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head [Video]

Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head

Sputnik V is a minus 18-degrees Celsius storage vaccine, informed Ravi Mathur, Global Logistics' Head, Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01."Sputnik V is a..

Credit: ANI     Duration: 01:43Published
Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO [Video]

Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO

The Sputnik V vaccine will be available in a few weeks after statutory clearances, informed Deepak Sapra, CEO of Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01. "Today,..

Credit: ANI     Duration: 01:02Published
150,000 doses of Sputnik V have arrived in India on 1st May | Oneindia News [Video]

150,000 doses of Sputnik V have arrived in India on 1st May | Oneindia News

Sputnik V is the Russian made covid vaccine with an efficacy rate above 90%. 150,000 doses of Sputnik have arrived at Hyderabad in India on Saturday. The vaccines will be handed over to Dr Reddy's..

Credit: Oneindia     Duration: 01:01Published
Equity indices trade flat, Infosys drops 3.8 pc [Video]

Equity indices trade flat, Infosys drops 3.8 pc

Equity benchmark indices traded flat during early hours on April 15 amid an interplay of resurgence in COVID-19 cases and the pace of vaccination. Investors tracked updates on the vaccines approval and..

Credit: ANI     Duration: 01:17Published

You Might Like


Russian made Sputnik V to be available at Delhi`s hospital from next week, check details

The first phase of the Sputnik V rollout by Apollo Hospitals and Dr Reddy`s Laboratories had started on a pilot basis on May 17 in Hyderabad and on May 18 in Vishakhapatnam.
Zee News - Published

Shrikant Chouhan: BUY SBI and Dr Reddy’s


TopNews - Published

Hyderabad's Rockwell collaborates with Dr Reddy's lab to provide vaccine freezers for Sputnik V rollout


newKerala.com - Published

Covid-19 vaccine tender: All bids junked by BMC

covid-19 vaccine tender: all bids junked by bmc
All nine potential suppliers disqualified due to lack of documentation; BMC turns to Dr. Reddy’s for experimental supply of Sputnik
Mid-Day - Published

Snowman Logistics partners with Dr. Reddy's for Sputnik vax in India


newKerala.com - Published

COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in India

Pune-based Serum Institute has also sought approval for test analysis and examination. Sputnik V is currently being manufactured by Dr Reddy's Lab.
DNA - Published

Sudarshan Sukhani: BUY HDFC, Dr Reddy’s, JSW Steel; SELL InfoEdge India


TopNews - Published

COVID-19 vaccine: 'Sputnik V' to be available in Delhi after June 20, says Kejriwal

The Delhi Government has been in talks with Dr Reddy's Laboratories for the supply of the 'Sputnik V' vaccine.
DNA - Published

No tie-up with any firm for supplying Sputnik V vaccine: Dr. Reddy's Laboratories, RDIF


newKerala.com - Published

Dr Reddy’s warns against fake Sputnik V suppliers

Amid reports coming in from various states about multiple Sputnik V suppliers responding to their global vaccine tenders, Dr Reddy's Labs said it is the sole custodian of the Russian vaccine in India...
IndiaTimes - Published

No partnership with any firm to supply Sputnik V: RDIF, Dr Reddy’s


Indian Express - Published

Not authorised any 3rd party to supply Sputnik V in India, legal action against unscrupulous elements: Dr Reddy’s & RDIF


IndiaTimes - Published

Dr Reddy’s fixes price of DRDO’s 2-DG anti-COVID drug at Rs 990 per sachet

DRDO's anti-COVID-19 drug 2-DG will be supplied to government hospitals, the central and state governments at a discounted price. 
Zee News - Published

If approved, Sputnik Light could become first single-dose vaccine to be launched in India

The two-dose Sputnik V had received the Indian drug regulator's permission for restricted emergency use with certain conditions on April 12. Dr Reddy's Laboratories is importing the vaccine for use in..
Zee News - Published

Sputnik V’s cold-storage needs may delay availability in region: Hospitals

The Russian-made Sputnik V vaccine may take a while to land in Pune. Private hospitals in the city that are mulling procurement said they are yet to receive a response to enquiries from Hyderabad-based..
IndiaTimes - Published

Mumbai: Agripada residents buy Sputnik for vaccination drive at nearby hospital

The Mumbai Central and Agripada Advanced Locality Management (MCA ALM) will next week roll out the city’s first citizen-driven cluster vaccination for residents of their area. The ALM has tied up..
IndiaTimes - Published

Sudarshan Sukhani: BUY Tech Mahindra, UPL, Zee and Dr Reddy’s


TopNews - Published

Dr Reddy’s developing new treatment options for COVID-19, says MD


Indian Express - Published Also reported by •IndiaTimes

Prices of Sputnik V COVID-19 vaccine may drop after local manufacturing begins: Dr Reddy's


newKerala.com - Published

DRDO’s anti-COVID-19 drug 2-DG likely to be available by mid-June: Dr Reddy`s

In a statement, Hyderabad based Dr Reddy's clarified that 2-DG is not yet available in the market and the commercial launch of the drug is expected by mid-June. 
Zee News - Published Also reported by •IndiaTimes

Dr Reddy's in talks with RDIF on Sputnik V for other countries

Dr Reddy's Laboratories, which is in a pact with Russian Direct Investment Fund to sell 125 million people doses (250 million vials) of Covid-19 vaccine Sputnik V in India, is holding parleys with RDIF..
IndiaTimes - Published

Sputnik V debuts on Co-Win at Rs 1,250 a dose as Dr Reddy’s ties with Apollo

Russian Covid-19 vaccine Sputnik V made its debut on the Co-Win Covid-19 vaccination platform with Dr Reddy’s Laboratories announcing a national tie-up with Apollo Hospitals for Russian Covid-19..
IndiaTimes - Published

DRDO's anti-COVID 2-DG drug an add-on, not substitute for other medicines: Dr Reddy's CEO


newKerala.com - Published

Dr Reddy's labs, Apollo hospitals launch pilot programme for administering Russian COVID vaccine Sputnik V


newKerala.com - Published

Apollo Hospitals, Dr Reddy's announce Covid-19 vaccination programme with Sputnik V

Apollo Hospitals and Dr Reddy's Laboratories on Monday said they are collaborating to initiate a Covid-19 vaccination programme with Sputnik V. The first phase of the programme will kick off with..
IndiaTimes - Published

This co inks pact with Dr Reddy's to mfg Sputnik V vaccine

Drug firm Shilpa Medicare on Monday said its arm has entered into a definitive agreement with Dr Reddy's Laboratories for manufacturing of Russian Covid-19 vaccine Sputnik V.
IndiaTimes - Published

Rajnath Singh to release first batch of DRDO's anti-COVID oral drug 2DG today

Developed by DRDO's INMAS, in collaboration with Dr Reddy's Laboratories in Hyderabad, the 2DG drug is an anti-Covid therapeutic application.
DNA - Published

Dr Reddy's posts Q4 profit of Rs 554 crore, revenues at Rs 4,728 crore


newKerala.com - Published

Dr Reddy's announces launch of Sputnik vaccine in Indian market


newKerala.com - Published

Dr Reddy's to get 36m doses of Sputnik V vaccine in next few months

Indian drug maker Dr. Reddy's Laboratories Ltd said on Friday it expects to get 36 million doses of Sputnik V Covid-19 vaccine in the next couple of months under its contract with Russia's sovereign..
IndiaTimes - Published

Russia’s Sputnik V COVID-19 vaccine to be available in India soon, know price and other details

Russia's Sputnik V vaccine will be available in India in collaboration with Dr. Reddy’s Lab. A dose of imported Sputnik 5V vaccine in India will be priced at Rs 995 including 5 percent GST.
Zee News - Published

Russian COVID-19 vaccine Sputnik V to cost Rs 995.40 per dose, reveals Dr Reddy`s Laboratories

Dr Reddy's Laboratories on Friday (May 14, 2021) announced that Russian COVID-19 vaccine Sputnik V will cost ₹995.40 + 5% GST per dose in India and the price of vaccines produced in the country may..
Zee News - Published

Dr Reddy's rolls out Sputnik V Covid-19 vaccine in India at around Rs 995 per dose

Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose being administered in Hyderabad on Friday..
IndiaTimes - Published

As India eyes Sputnik rollout, experts question efficacy data

Even as India is gearing up to roll out Russian Covid-19 vaccine Sputnik V next week, a group of international experts has raised serious questions about the data discrepancies and substandard..
IndiaTimes - Published

Dr Reddy's to manufacture baricitinib for Covid treatment


newKerala.com - Published

2-deoxy-D-glucose: DRDO`s anti-COVID-19 drug is safe, will help patients recover faster, says INMAS scientist

Anti-COVID-19 drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy`s Laboratories (DRL), Hyderabad.
Zee News - Published

Dr Reddy's inks licensing pact with Eli Lilly for Covid-19 treatment drug

Dr Reddy's Laboratories on Tuesday said it has inked a licensing pact with Eli Lilly and Company to produce Baricitinib in the country for treatment of Covid-19.
IndiaTimes - Published

Mumbai: Sensex jumps 296 points, pharma stocks surge

mumbai: sensex jumps 296 points, pharma stocks surge
Among stocks, Coal India moved up by 8 per cent to Rs 148.10 per share. Pharma majors Dr Reddy`s and Sun Pharma were up by 3 per cent and 2.7 per cent respectively.
Mid-Day - Published

Equities on upswing, Dr Reddy's gains 3.3 pc


newKerala.com - Published

Sensex surges over 350 points in early trade; Nifty tops 14,900

sensex surges over 350 points in early trade; nifty tops 14,900
Dr Reddy`s was the top gainer in the Sensex pack, rising over 2 per cent, followed by ONGC, HDFC, IndusInd Bank, ICICI Bank, Sun Pharma and Kotak Bank.
Mid-Day - Published

Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use

A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has received the Drugs Controller General of India (DCGI) nod for emergency use as adjunct therapy for..
IndiaTimes - Published

DCGI gives nod to anti-COVID drug developed by DRDO for emergency use

The Drugs Controller General of India (DCGI) on Saturday (May 8, 2021) approved drug 2-deoxy-D-glucose (2-DG) which is developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO in..
Zee News - Published

Sensex ends 465 points lower, Nifty slips below 14,500 amid lockdown and IPL suspension

The 30-share BSE index ended 465.01 points or 0.95 percent lower at 48,253.51, and the broader NSE Nifty slumped 137.65 points or 0.94 percent to 14,496.50. Dr Reddy's was the top loser in the Sensex..
Zee News - Published

Russia`s COVID-19 vaccine Sputnik V arrives in Hyderabad

Last month, the Drug Controller General (DCGI) had issued permission for Dr. Reddy's Laboratories to import the Russian vaccine to India for emergency use. The rollout of the Russian vaccine is..
Zee News - Published

Sensex slumps 984 points, Nifty ends below 14,650; financial stocks lead sell off

HDFC twins were the top losers in the Sensex pack, shedding over 4 percent, followed by ICICI Bank, Kotak Bank, Asian Paints, M&M, HUL, TCS, and Maruti. On the other hand, ONGC, Sun Pharma, Dr. Reddy,..
Zee News - Published

Mitesh Thakkar: BUY ICICI Lombard, Axis Bank, Dr Reddy’s; SELL HCL Technologies


TopNews - Published


 Page 1  〉